Published by Josh White on 25th October 2021
(Sharecast News) - Biotechnology company Allergy Therapeutics announced positive top-line results from its exploratory field study 'G309' to evaluate the efficacy and safety of its short-course subcutaneous allergen-specific immunotherapy candidate 'Grass MATA MPL'.
URL: http://www.digitallook.com/dl/news/story/32214219/...